|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61F 9/00 | (2006.01) |
| A61F2250/0067 | (2013.01) | ||
| A61F 9/007 | (2006.01) | ||
| A61F 9/0017 | (2013.01) |
| (11) | Number of the document | 3603590 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19181962.2 |
| Date of filing the European patent application | 2014-03-10 | |
| (97) | Date of publication of the European application | 2020-02-05 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-11 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361788731 P | 2013-03-15 | US |
| (72) |
Haffner, David , US
Burns, Thomas W. , US
Heitzmann, Harold , US
Curry, Kenneth Martin , US
|
| (73) |
Dose Medical Corporation ,
26051 Merit Circle, Suite 103, Laguna Hills, CA 92653,
US
|
| (54) | IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES |
| IMPLANTS WITH CONTROLLED DRUG DELIVERY FEATURES |